These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8422194)

  • 1. Quinolone resistance: a practical perspective.
    Wood CA
    Arch Intern Med; 1993 Jan; 153(1):120-1. PubMed ID: 8422194
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinolone resistance: an alternative perspective.
    Fish DN; Piscitelli SC; Danziger LH
    Arch Intern Med; 1992 Jun; 152(6):1329-30. PubMed ID: 1301015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinolone antimicrobial agents.
    Neu HC
    Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of bacterial resistance to quinolones].
    Yoshida H
    Nihon Saikingaku Zasshi; 1996 Oct; 51(4):973-92. PubMed ID: 8994343
    [No Abstract]   [Full Text] [Related]  

  • 6. Quinolone resistance in Pseudomonas aeruginosa.
    Hashmi ZS; Smith JM
    J Antimicrob Chemother; 1994 Apr; 33(4):881-3. PubMed ID: 8056710
    [No Abstract]   [Full Text] [Related]  

  • 7. High-level quinolone resistance in Pseudomonas aeruginosa.
    Piddock LJ; Panchal S; Inglis TJ; Hawkey PM
    J Antimicrob Chemother; 1992 Aug; 30(2):229-31. PubMed ID: 1399933
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical perspectives of quinolone resistance in Pseudomonas aeruginosa.
    Dalhoff A
    Antibiot Chemother (1971); 1991; 44():221-39. PubMed ID: 1801641
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States.
    Blumberg HM; Rimland D
    Infect Control Hosp Epidemiol; 1995 Nov; 16(11):620-1. PubMed ID: 8601677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of resistance of Pseudomonas aeruginosa isolates to select antibiotics].
    Sekowska A; Janicka G; Wojda M; Wróblewska J; Manysiak S
    Pol Merkur Lekarski; 2005 Aug; 19(110):169-71. PubMed ID: 16245425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
    Liu JY; Wei YG; Guo HY
    Yao Xue Xue Bao; 2001 Jun; 36(6):419-22. PubMed ID: 12585124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late quinolone resistance in Pseudomonas aeruginosa.
    Smith JM; Hashmi ZS
    J Antimicrob Chemother; 1991 Apr; 27(4):555-6. PubMed ID: 1906859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance of Pseudomonas aeruginosa with special reference to new quinolones.
    Iyobe S; Hirai K; Hashimoto H
    Antibiot Chemother (1971); 1991; 44():209-14. PubMed ID: 1801639
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinolone susceptibility of norA-disrupted Staphylococcus aureus.
    Yamada H; Kurose-Hamada S; Fukuda Y; Mitsuyama J; Takahata M; Minami S; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2308-9. PubMed ID: 9333072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolones in sweat and quinolone resistance.
    Hawkey PM
    Lancet; 1997 Jan; 349(9046):148-9. PubMed ID: 9111534
    [No Abstract]   [Full Text] [Related]  

  • 19. In-vitro activity of quinolones against different species of staphylococci of recent clinical isolation.
    Rabagliati AM; Fiorio P; Cavallo R; Mills V; Penna R
    J Chemother; 1991 Jan; 3 Suppl 1():176-8. PubMed ID: 12041759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of resistance to quinolone antimicrobials.
    Smith J
    Chemioterapia; 1987 Jun; 6(2 Suppl):208-9. PubMed ID: 3334558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.